Literature DB >> 10711408

Cryopreserved primary hepatocytes as a constantly available in vitro model for the evaluation of human and animal drug metabolism and enzyme induction.

J G Hengstler1, D Utesch, P Steinberg, K L Platt, B Diener, M Ringel, N Swales, T Fischer, K Biefang, M Gerl, T Böttger, F Oesch.   

Abstract

The use of primary hepatocytes is now well established for both studies of drug metabolism and enzyme induction. Cryopreservation of primary hepatocytes decreases the need for fresh liver tissue. This is especially important for research with human hepatocytes because availability of human liver tissue is limited. In this review, we summarize our research on optimization and validation of cryopreservation techniques. The critical elements for successful cryopreservation of hepatocytes are (1) the freezing protocol, (2) the concentration of the cryoprotectant [10% dimethyl-sulfoxide (DMSO)], (3) slow addition and removal of DMSO, (4) carbogen equilibration during isolation of hepatocytes and before cryopreservation, and (5) removal of unvital hepatocytes by Percoll centrifugation after thawing. Hepatocytes of human, monkey, dog, rat, and mouse isolated and cryopreserved by our standard procedure have a viability > or = 80%. Metabolic capacity of cryopreserved hepatocytes determined by testosterone hydroxylation, 7-ethoxyresorufin-O-de-ethylase (EROD), 7-ethoxycoumarin-O-deethylase (ECOD), glutathione S-transferase, UDP-glucuronosyl transferase, sulfotransferase, and epoxide hydrolase activities is > or = 60% of freshly isolated cells. Cryopreserved hepatocytes in suspension were successfully applied in short-term metabolism studies and as a metabolizing system in mutagenicity investigations. For instance, the complex pattern of benzo[a]pyrene metabolites including phase II metabolites formed by freshly isolated and cryopreserved hepatocytes was almost identical. For the study of enzyme induction, a longer time period and therefore cryopreserved hepatocyte cultures are required. We present a technique with cryopreserved hepatocytes that allows the induction of testosterone metabolism with similar induction factors as for fresh cultures. However, enzyme activities of induced hepatocytes and solvent controls were smaller in the cryopreserved cells. In conclusion, cryopreserved hepatocytes held in suspension can be recommended for short-term metabolism or toxicity studies. Systems with cryopreserved hepatocyte cultures that could be applied for studies of enzyme induction are already in a state allowing practical application, but may be further optimized.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10711408     DOI: 10.1081/dmr-100100564

Source DB:  PubMed          Journal:  Drug Metab Rev        ISSN: 0360-2532            Impact factor:   4.518


  42 in total

1.  Effect of cryopreservation on the properties of human endometrial stromal cells used in embryo co-culture systems.

Authors:  Ivan Bochev; Kalina Belemezova; Atanas Shterev; Stanimir Kyurkchiev
Journal:  J Assist Reprod Genet       Date:  2016-01-12       Impact factor: 3.412

Review 2.  Hepatocyte cryopreservation: is it time to change the strategy?

Authors:  Xavier Stéphenne; Mustapha Najimi; Etienne M Sokal
Journal:  World J Gastroenterol       Date:  2010-01-07       Impact factor: 5.742

3.  Microengineered cell and tissue systems for drug screening and toxicology applications: Evolution of in-vitro liver technologies.

Authors:  O B Usta; W J McCarty; S Bale; M Hegde; R Jindal; A Bhushan; I Golberg; M L Yarmush
Journal:  Technology (Singap World Sci)       Date:  2015-03

Review 4.  Assessment of stem cell differentiation based on genome-wide expression profiles.

Authors:  Patricio Godoy; Wolfgang Schmidt-Heck; Birte Hellwig; Patrick Nell; David Feuerborn; Jörg Rahnenführer; Kathrin Kattler; Jörn Walter; Nils Blüthgen; Jan G Hengstler
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2018-07-05       Impact factor: 6.237

Review 5.  Cellular therapy and bioartificial approaches to liver replacement.

Authors:  Jason A Wertheim; Pedro M Baptista; Alejandro Soto-Gutierrez
Journal:  Curr Opin Organ Transplant       Date:  2012-06       Impact factor: 2.640

6.  Cellular uptake and cytotoxicity of a near-IR fluorescent corrole-TiO2 nanoconjugate.

Authors:  Carl M Blumenfeld; Bryce F Sadtler; G Esteban Fernandez; Lily Dara; Cathie Nguyen; Felix Alonso-Valenteen; Lali Medina-Kauwe; Rex A Moats; Nathan S Lewis; Robert H Grubbs; Harry B Gray; Karn Sorasaenee
Journal:  J Inorg Biochem       Date:  2014-06-28       Impact factor: 4.155

7.  Isolation of Primary Mouse Hepatocytes for Nascent Protein Synthesis Analysis by Non-radioactive L-azidohomoalanine Labeling Method.

Authors:  Esam S B Salem; Kazutoshi Murakami; Toshimasa Takahashi; Elise Bernhard; Vishnupriya Borra; Mridula Bethi; Takahisa Nakamura
Journal:  J Vis Exp       Date:  2018-10-23       Impact factor: 1.355

8.  Cryopreserved human hepatocytes as alternative in vitro model for cytochrome p450 induction studies.

Authors:  Martha Garcia; Joseph Rager; Qing Wang; Robert Strab; Ismael J Hidalgo; Albert Owen; Jibin Li
Journal:  In Vitro Cell Dev Biol Anim       Date:  2003 Jul-Aug       Impact factor: 2.416

9.  Localization of P-gp (Abcb1) and Mrp2 (Abcc2) in freshly isolated rat hepatocytes.

Authors:  Daniel A J Bow; Jennifer L Perry; David S Miller; John B Pritchard; Kim L R Brouwer
Journal:  Drug Metab Dispos       Date:  2007-10-22       Impact factor: 3.922

10.  Comparative metabolism of the designer drug 4-methylthioamphetamine by hepatocytes from man, monkey, dog, rabbit, rat and mouse.

Authors:  Helena Carmo; Jan G Hengstler; Douwe de Boer; Michael Ringel; Félix Carvalho; Eduarda Fernandes; Fernando Remião; Lesseps A dos Reys; Franz Oesch; Maria de Lourdes Bastos
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-12-16       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.